Asensus Surgical Inc. buy krebskrebs
Start price
17.05.21
/
50%
€1.42
Target price
17.05.22
€2.00
Performance (%)
-73.34%
End price
18.05.22
€0.38
Summary
This prediction ended on 18.05.22 with a price of €0.38. Massive losses of -73.34% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Asensus Surgical Inc. | - | - | - | - |
| iShares Core DAX® | 1.301% | -1.386% | 12.259% | 59.752% |
| iShares Nasdaq 100 | 0.612% | -4.172% | 1.687% | 86.147% |
| iShares Nikkei 225® | 8.772% | 9.777% | 30.041% | 63.047% |
| iShares S&P 500 | 0.254% | -2.301% | 0.794% | 57.981% |
Comments by krebskrebs for this prediction
In the thread Transenterix Inc diskutieren
Buy mit Kursziel 2,0
In the thread Trading Transenterix Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten

